Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
Academic Article
- Overview
- Identity
- Additional document info
- View All
Overview
publication date
- May 31, 2016